Komal has over 25 years of global experience in pharma, in various therapeutic areas including early and late phase oncology. Komal has worked at small and large companies providing tactical and strategic input and execution of clinical studies, throughout the protocol life cycle.  In addition to running clinical trials, Komal has also supported several successful sNDA/NDA submissions. 

Prior to joining Oncoverity, Komal worked at Pfizer managing trials in Multiple Myeloma. Prior to that she worked 10 years in biotech, including 4 years at Ichnos Sciences which was a new company formed as a spin-off from Glenmark Pharmaceuticals.